Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CTVA | Common Stock | Options Exercise | $1.24M | +39.7K | +31.39% | $31.22 | 166K | May 14, 2024 | Direct | |
transaction | CTVA | Common Stock | Sale | -$2.28M | -39.7K | -23.89% | $57.41 | 127K | May 14, 2024 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CTVA | Non-Qualified Stock Options | Options Exercise | $0 | -39.7K | -100% | $0.00* | 0 | May 14, 2024 | Common Stock | 39.7K | $31.22 | Direct | F3 |
Id | Content |
---|---|
F1 | The price reported represents the weighted average price. These shares were sold in multiple transactions at prices ranging from $57.40 to $57.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F2 | Includes acquisition of 28.0639 shares pursuant to dividend reinvestment. |
F3 | This option is fully vested and exercisable. |